Published in Can J Psychiatry on April 01, 2004
HCN Channel Targets for Novel Antidepressant Treatment. Neurotherapeutics (2017) 0.79
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry (2003) 3.85
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg (2011) 3.30
Is DSM-IV bereavement exclusion for major depressive episode relevant to severity and pattern of symptoms? A case-control, cross-sectional study. J Clin Psychiatry (2009) 2.54
Hypnotics and Triazolobenzodiazepines--Best Predictors of High-Dose Benzodiazepine Use: Results from the Luxembourg National Health Insurance Registry. Psychother Psychosom (2015) 2.01
Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res (2005) 1.66
Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder. J Clin Psychopharmacol (2002) 1.52
Remission in schizophrenia: critical and systematic review. Harv Rev Psychiatry (2012) 1.51
Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychother Psychosom (2008) 1.19
Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol (2002) 1.12
Switching from brand-name to generic psychotropic medications: a literature review. CNS Neurosci Ther (2010) 1.11
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction. Can J Psychiatry (2005) 1.06
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia. Can J Psychiatry (2005) 1.05
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Int J Neuropsychopharmacol (2009) 1.05
Hypomania induced by adjunctive lamotrigine. Am J Psychiatry (2003) 1.01
A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Eur Neuropsychopharmacol (2004) 1.01
Mutants of GABA transaminase (POP2) suppress the severe phenotype of succinic semialdehyde dehydrogenase (ssadh) mutants in Arabidopsis. PLoS One (2008) 1.00
Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching. Int Clin Psychopharmacol (2010) 0.97
Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia. Schizophr Res (2005) 0.96
Invasion of the Arabidopsis genome by the tobacco retrotransposon Tnt1 is controlled by reversible transcriptional gene silencing. Plant Physiol (2008) 0.96
Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment? J Psychopharmacol (2012) 0.92
Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment. Can J Psychiatry (2003) 0.92
Risperidone-induced morning pseudoneutropenia. Am J Psychiatry (2005) 0.90
A non-canonical plant microRNA target site. Nucleic Acids Res (2014) 0.89
The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. Schizophr Bull (2004) 0.87
Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia. J Clin Psychiatry (2002) 0.87
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. J Clin Psychopharmacol (2002) 0.86
Successful initiation of clozapine treatment despite morning pseudoneutropenia. Int J Neuropsychopharmacol (2005) 0.84
Gabapentin in the treatment of antipsychotic-induced akathisia in schizophrenia. Int Clin Psychopharmacol (2005) 0.84
Seizures, coma, and coagulopathy following olanzapine overdose. Can J Psychiatry (2005) 0.84
Weight loss during prolonged branched-chain amino acid treatment for tardive dyskinesia in a patient with schizophrenia. Aust N Z J Psychiatry (2006) 0.83
Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia: a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use. Can J Psychiatry (2004) 0.81
Diabetes insipidus secondary to combination atypical antipsychotic and lithium use in a bipolar disorder patient: a case report. Prim Care Companion CNS Disord (2011) 0.80
Topiramate-induced weight loss in schizophrenia: a retrospective case series study. Can J Clin Pharmacol (2007) 0.79
Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine. J Clin Psychopharmacol (2011) 0.79
Emerging clinical trends and perspectives on comorbid patterns of mental disorders in research. Int J Methods Psychiatr Res (2014) 0.79
Aripiprazole-Induced Hypoprolactinemia in an Adult Male with First-Episode Psychosis. Clin Schizophr Relat Psychoses (2015) 0.78
Risperidone-induced immunoallergic hepatitis. Am J Psychiatry (2005) 0.78
Tardive dyskinesia associated with olanzapine in a neuroleptic-naive patient with schizophrenia. Can J Psychiatry (2004) 0.78
Gabapentin-induced paradoxical exacerbation of psychosis in a patient with schizophrenia. Can J Psychiatry (2002) 0.78
Normal and pathological aging of attention in presymptomatic Huntington's, Huntington's and Alzheimer's Disease, and nondemented elderly subjects. Psychother Psychosom (2008) 0.78
The need for a behavioural science focus in research on mental health and mental disorders. Int J Methods Psychiatr Res (2014) 0.78
Migraine headache prophylaxis and treatment with low-dose mirtazapine. Int Clin Psychopharmacol (2003) 0.77
Alternative pharmacotherapy for trichotillomania: a report of successful bupropion use. J Clin Psychiatry (2004) 0.77
Patient online report of selective serotonin reuptake inhibitor-induced persistent postwithdrawal anxiety and mood disorders. Psychother Psychosom (2012) 0.77
Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. Can J Clin Pharmacol (2006) 0.76
Cognitive impairment in systemic lupus erythematosus women with elevated autoantibodies and normal single photon emission computerized tomography. Psychother Psychosom (2012) 0.76
Beyond DSM-IV bereavement exclusion criterion E for major depressive disorder. Psychother Psychosom (2010) 0.76
Late-onset agranulocytosis in a patient with schizophrenia after 17 months of clozapine treatment. J Clin Psychopharmacol (2003) 0.76
ECT in delusional depression with multiple sclerosis. Am J Psychiatry (2004) 0.76
Nine-year prophylactic maintenance electroconvulsive therapy in an 89-year-old woman with recurrent psychotic major depressive disorder. Am J Geriatr Psychiatry (2007) 0.76
Non-response to consecutive antidepressant therapy caused by CYP2D6 ultrarapid metabolizer phenotype. Int J Neuropsychopharmacol (2008) 0.76
Persistent postwithdrawal disorders induced by paroxetine, a selective serotonin reuptake inhibitor, and treated with specific cognitive behavioral therapy. Psychother Psychosom (2014) 0.75
Possible association of syndrome of inappropriate secretion of antidiuretic hormone with St John's wort use. J Clin Psychopharmacol (2014) 0.75
Obsessive-compulsive symptoms in schizophrenia induced by risperidone and responding to fluoxetine. Can J Psychiatry (2003) 0.75
Clozapine for first-episode schizophrenia. Am J Psychiatry (2002) 0.75
Cocaine Use Disorder Treated with Specific Cognitive Behavioral Therapy and Adjunctive Propranolol. Psychother Psychosom (2015) 0.75
Donepezil-associated mania in two patients who were using donepezil without a prescription. J Clin Psychopharmacol (2014) 0.75
Using the rating scale for psychotic symptoms to characterize delusions expressed in a schizophrenia patient with "Internet psychosis". Can J Psychiatry (2002) 0.75
Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism. Psychiatry Clin Neurosci (2007) 0.75
Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine. Pharmacotherapy (2004) 0.75
First- and second-generation antipsychotics. Can J Psychiatry (2010) 0.75
Psychosis secondary to ALS in the absence of dementia: a convincing case. J Neuropsychiatry Clin Neurosci (2011) 0.75
Fungal dermatitis with olanzapine in schizophrenia. Can J Psychiatry (2003) 0.75